Literature DB >> 19288224

Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination.

Torquil Watt1, Jakob Bue Bjorner, Mogens Groenvold, Ase Krogh Rasmussen, Steen Joop Bonnema, Laszlo Hegedüs, Ulla Feldt-Rasmussen.   

Abstract

OBJECTIVE: To establish a reliable and valid scale structure of a patient-reported outcome measuring thyroid-specific quality of life.
METHODS: The 98-item ThyPRO questionnaire was administered to patients with benign thyroid diseases at two university hospitals. Multi-trait scaling was performed, evaluating lack of convergent validity (item-own scale polyserial correlation <0.40) or lack of discriminant validity (item-other scale correlation higher than item-own scale correlation) of the hypothesized scale structure. Analyses were repeated in clinical and sociodemographic subgroups and with Pearson correlations. Reliability was estimated by Cronbach's alpha, both conventionally and with polychoric correlations.
RESULTS: In total, 904 patients (69%) responded. Initial multitrait scaling analysis identified 25 scaling errors. Twelve items were omitted from the scale structure, and a re-analysis showed complete convergent validity and only two instances of lack of discriminant validity. Pearson correlations yielded similar results. Across all subgroups, convergent validity was complete, and discriminant validity was found in 99.2% of tests. Lack of discriminant validity was mainly between physical symptoms and psychological and disease-impact scales. Cronbach's alpha was acceptable (>0.70, >0.80 with polychoric correlations) for all 13 scales.
CONCLUSION: A reliable scale structure displaying complete convergent and almost complete discriminant validity was established in general analyses and in distinct clinical subgroups of patients with benign thyroid diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19288224     DOI: 10.1007/s11136-009-9460-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  29 in total

1.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

2.  Putting Wilson and Cleary to the test: analysis of a HRQOL conceptual model using structural equation modeling.

Authors:  Karen H Sousa; Oi-Man Kwok
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

3.  Tests of data quality, scaling assumptions, and reliability of the Danish SF-36.

Authors:  J B Bjorner; M T Damsgaard; T Watt; M Groenvold
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

4.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

5.  Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism.

Authors:  J J Fahrenfort; A M Wilterdink; E A van der Veen
Journal:  Psychoneuroendocrinology       Date:  2000-02       Impact factor: 4.905

Review 6.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

Review 7.  Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis.

Authors:  Russell T Joffe; Michael Brimacombe; Anthony J Levitt; Alex Stagnaro-Green
Journal:  Psychosomatics       Date:  2007 Sep-Oct       Impact factor: 2.386

8.  Disease-specific assessment of quality of life after decompression surgery for Graves' ophthalmopathy.

Authors:  M Tehrani; F Krummenauer; W J Mann; S Pitz; H B Dick; G J Kahaly
Journal:  Eur J Ophthalmol       Date:  2004 May-Jun       Impact factor: 2.597

Review 9.  Quality of life in patients with benign thyroid disorders. A review.

Authors:  Torquil Watt; Mogens Groenvold; Ase Krogh Rasmussen; Steen Joop Bonnema; Laszlo Hegedüs; Jakob Bue Bjorner; Ulla Feldt-Rasmussen
Journal:  Eur J Endocrinol       Date:  2006-04       Impact factor: 6.664

10.  Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives.

Authors:  Torquil Watt; Laszlo Hegedüs; Ase Krogh Rasmussen; Mogens Groenvold; Steen Joop Bonnema; Jakob Bue Bjorner; Ulla Feldt-Rasmussen
Journal:  Thyroid       Date:  2007-07       Impact factor: 6.568

View more
  35 in total

Review 1.  Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level.

Authors:  Jacqueline Jonklaas
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-10       Impact factor: 3.243

2.  Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study.

Authors:  Anjali Mishra; Mayilvaganan Sabaretnam; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

3.  Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves' Orbitopathy.

Authors:  Luigi Bartalena; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2020-09-21

4.  Quality of life is not influenced by the extent of surgery in patients with benign goiter.

Authors:  F Hubertus Schmitz-Winnenthal; Simon Schimmack; Ben Lawrence; Uwe Maier; Miriam Heidmann; Markus W Buchler; Moritz von Frankenberg
Journal:  Langenbecks Arch Surg       Date:  2011-08-02       Impact factor: 3.445

5.  Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?

Authors:  Torquil Watt; Laszlo Hegedüs; Jakob Bue Bjorner; Mogens Groenvold; Steen Joop Bonnema; Ase Krogh Rasmussen; Ulla Feldt-Rasmussen
Journal:  Eur Thyroid J       Date:  2012-09-29

6.  Measurement properties of ThyPRO short-form (ThyPRO-39) for use in Chinese patients with benign thyroid diseases.

Authors:  Carlos K H Wong; Edmond P H Choi; Y C Woo; Brian H H Lang
Journal:  Qual Life Res       Date:  2018-04-18       Impact factor: 4.147

7.  Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.

Authors:  Carrie C Lubitz; Lucia De Gregorio; Abbey L Fingeret; Konstantinos P Economopoulos; Diana Termezawi; Mursal Hassan; Sareh Parangi; Antonia E Stephen; Elkan F Halpern; Karen Donelan; J Shannon Swan
Journal:  Thyroid       Date:  2016-12-15       Impact factor: 6.568

8.  High Level of Agreement between Electronic and Paper Mode of Administration of a Thyroid-Specific Patient-Reported Outcome, ThyPRO.

Authors:  Sofie Larsen Rasmussen; Lars Rejnmark; Eva Ebbehøj; Ulla Feldt-Rasmussen; Åse Krogh Rasmussen; Jakob Bue Bjorner; Torquil Watt
Journal:  Eur Thyroid J       Date:  2016-03-04

9.  Few items in the thyroid-related quality of life instrument ThyPRO exhibited differential item functioning.

Authors:  Torquil Watt; Mogens Groenvold; Laszlo Hegedüs; Steen Joop Bonnema; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen; Jakob Bue Bjorner
Journal:  Qual Life Res       Date:  2013-06-30       Impact factor: 4.147

10.  Improvement of quality of life in patients with benign goiter after surgical treatment.

Authors:  Branka R Bukvic; Vladan R Zivaljevic; Sandra B Sipetic; Aleksandar D Diklic; Katarina M Tausanovic; Ivan R Paunovic
Journal:  Langenbecks Arch Surg       Date:  2014-07-08       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.